Achieve Life Sciences (ACHV) Capital Expenditures (2010 - 2023)

Achieve Life Sciences (ACHV) has 12 years of Capital Expenditures data on file, last reported at $6000.0 in Q4 2023.

• Quarterly Capital Expenditures changed N/A year-over-year to $6000.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $21000.0 (changed N/A YoY) and the FY2025 annual result came in at $3000.0, changed N/A from the prior year.
• Capital Expenditures grew to $6000.0 in Q4 2023, from $3000.0 in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $54000.0 in Q1 2019 to a low of -$2000.0 in Q2 2019.
• A 3-year average of $10857.1 and a median of $3000.0 in 2020 frame the typical range for Capital Expenditures.
• The widest YoY moves for Capital Expenditures: up 700.0% in 2020, down 96.3% in 2020.
• Tracing ACHV's Capital Expenditures over 3 years: stood at $1000.0 in 2019, then surged by 200.0% to $3000.0 in 2020, then surged by 100.0% to $6000.0 in 2023.
• The last three Capital Expenditures figures came in at $6000.0 (Q4 2023), $3000.0 (Q3 2020), and $12000.0 (Q2 2020), per Business Quant data.